Ticker League

AstraZeneca (AZN) Free Cash Flow Bridge

Pinpoint what moved AstraZeneca's FCF from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

-11.70%

OCF YoY

+9.33%

Capex YoY

+57.99%

FCF Conversion Δ

-13.4 pp

Free cash flow bridge for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: -$1.07B

FCF bridge breakdown for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$9.14B
  • Operating Cash Flow$1.22B
  • Capital Expenditure-$2.29B
  • Free Cash Flow$8.07B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology